Showing results (391-400 of 1,543) with videos related to
Sort By:
Pageof 155
Cancer Reports (Hoboken, N.J.)|April 14, 2026
Hemophagocytic Lymphohystiocytosis in a Patient With Suspected Acute Myeloid Leukemia and Recent Viral Illness Compatible With Dengue: A Case Report and Literature ReviewHalima Saleh, Sariya Khan, Huda Albraim, et al.Cancer Reports (Hoboken, N.J.)|May 8, 2026
Genetic and Immunohistochemical Profiling of Malignant Mesothelioma With Brain Metastasis: A Report of Two CasesPaul M Harary, Yusuke S Hori, Ruchit Jain, et al.Cancer Reports (Hoboken, N.J.)|May 8, 2026
Virtual Screening of Traditional Chinese Medicine Natural Product Inhibitors Targeting AQP1 for Bladder CancerDi Liu, Qing-Yu ZhangCancer Reports (Hoboken, N.J.)|August 14, 2026
Therapeutic and Predicted Significance of PKLR in Patients With CholangiocarcinomaBiyan Gong, Xuejun Xu, Tubing Xu, et al.Cancer Reports (Hoboken, N.J.)|August 20, 2026
ANXA1/FPR Signaling Contribute to Paclitaxel Resistance in Ovarian Cancer Through PI3K/AKT-Associated PGC1α RegulationZhou Li, Jiang Mingrui, Zhou Yueyang, et al.Cancer Reports (Hoboken, N.J.)|August 16, 2026
Real-World Outcomes of Acute Myeloid Leukemia Patients Undergoing Treatment With Tyrosine Kinase Inhibitor (TKI) Therapy Targeting FLT3, IDH1, or IDH2Manuel R Espinoza-Gutarra, Brooke Jarret, Xiaoliang Wang, et al.Cancer Reports (Hoboken, N.J.)|August 6, 2026
Human Epidermal Growth Factor Receptor 2-Positive, Claudin-18 Isoform 2-Positive, Mismatch Repair-Deficient Gastric Cancer Revealed by Immunohistochemical Analysis of Surgical Specimens: A Case ReportDaichi Takagi, Mikito Mori, Kiyohiko Shuto, et al.Cancer Reports (Hoboken, N.J.)|September 7, 2026
Progesterone Is Associated With Increased Vasohibin-2 Expression, Tubulin Detyrosination, and Paclitaxel Sensitivity in PR-Negative Ovarian Cancer CellsTakahiro Koyanagi, Yasushi Saga, Yoshifumi Takahashi, et al.Cancer Reports (Hoboken, N.J.)|August 6, 2026
Harnessing Repurposed Drugs to Enhance Temozolomide Efficacy in GlioblastomaAli Nakhaei, Atefeh Taghavi, Amir R Afshari, et al.Cancer Reports (Hoboken, N.J.)|August 9, 2026
Targeting Spatiotemporal Heterogeneity of oncomiRNAs: A New Frontier in Cancer TherapyT Jeethy Ram, Muralee DamodaranPageof 155